Standard BioTools Inc. (LAB)

NASDAQ: LAB · IEX Real-Time Price · USD
+0.05 (1.90%)
Sep 29, 2023, 10:35 AM EDT - Market open

Total Valuation

LAB has a market cap or net worth of $232.55 million. The enterprise value is $187.29 million.

Market Cap 232.55M
Enterprise Value 187.29M

Important Dates

The next estimated earnings date is Tuesday, November 7, 2023, after market close.

Earnings Date Nov 7, 2023
Ex-Dividend Date n/a

Share Statistics

LAB has 78.96 million shares outstanding. The number of shares has increased by 1.09% in one year.

Shares Outstanding 78.96M
Shares Change (YoY) +1.09%
Shares Change (QoQ) -0.52%
Owned by Insiders (%) 2.79%
Owned by Institutions (%) 61.67%
Float 52.48M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.16
Forward PS 4,697.48
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.78
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.91

Current Ratio 3.91
Quick Ratio 3.36
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -17.78

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -22.00%
Return on Capital (ROIC) -35.70%
Revenue Per Employee $201,629
Profits Per Employee -$160,906
Employee Count 523
Asset Turnover 0.28
Inventory Turnover 2.64


Income Tax -79,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +142.86% in the last 52 weeks. The beta is 1.47, so LAB's price volatility has been higher than the market average.

Beta (1Y) 1.47
52-Week Price Change +142.86%
50-Day Moving Average 2.70
200-Day Moving Average 2.12
Relative Strength Index (RSI) 50.00
Average Volume (30 Days) 252,350

Short Selling Information

The latest short interest is 2.74 million, so 3.47% of the outstanding shares have been sold short.

Short Interest 2.74M
Short Previous Month 2.55M
Short % of Shares Out 3.47%
Short % of Float 5.22%
Short Ratio (days to cover) 10.81

Income Statement

In the last 12 months, LAB had revenue of $105.45 million and -$84.15 million in losses. Loss per share was -$1.06.

Revenue 105.45M
Gross Profit 46.11M
Operating Income -84.18M
Pretax Income -84.23M
Net Income -84.15M
EBITDA -76.44M
EBIT -79.75M
Loss Per Share -$1.06
Full Income Statement

Balance Sheet

The company has $142.30 million in cash and $101.39 million in debt, giving a net cash position of $40.92 million or $0.52 per share.

Cash & Cash Equivalents 142.30M
Total Debt 101.39M
Net Cash 40.92M
Net Cash Per Share $0.52
Equity / Book Value -113.39M
Book Value Per Share -1.44
Working Capital 136.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$61.61 million and capital expenditures -$3.87 million, giving a free cash flow of -$65.47 million.

Operating Cash Flow -61.61M
Capital Expenditures -3.87M
Free Cash Flow -65.47M
FCF Per Share -$0.83
Full Cash Flow Statement


Gross margin is 43.73%, with operating and profit margins of -79.83% and -79.80%.

Gross Margin 43.73%
Operating Margin -79.83%
Pretax Margin -79.88%
Profit Margin -79.80%
EBITDA Margin -72.49%
EBIT Margin -75.62%
FCF Margin -62.09%

Dividends & Yields

LAB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -36.88%
FCF Yield -28.69%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -1.09%
Shareholder Yield -1.09%

Analyst Forecast

The average price target for LAB is $4.00, which is 35.82% higher than the current price. The consensus rating is "Buy".

Price Target $4.00
Price Target Difference 35.82%
Analyst Consensus Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a